Analysis of CD21/CR2 (Human) by ELISA (CAT#: STEM-MB-0721-LGZ)
Introduction
CD21/CR2 is a dendritic cell marker and a viral receptor for EBV and HHV8, expressed in follicular dendritic cells, marginal zone cells and mantle cells.
Enzyme-linked immunosorbent assay (ELISA) is an enzyme-labeled solid phase immunoassay technique. Its basic principle is to bind the antigen (or antibody) to the solid phase carrier, and the antigen (or antibody) and a certain enzyme link to enzyme labeled antigen (or antibody). During detection, the sample to be tested and the enzymic antigen (or antibody) react with the antigen (or antibody) on the solid phase carrier according to certain procedures, and then remove the unreacted part by washing method. After adding the substrate, the substrate is catalyzed by the enzyme on the solid phase carrier to produce colored substances. Through qualitative or quantitative detection of the amount of colored products, the content of the substance to be measured in the sample can be determined.
Applications
Oncology & Cancer
Procedure
1. Add standards or samples to each well and incubate. 2. Pour off the liquid in the well, biotinylated antibody working solution and incubate. 3. Add enzyme conjugate working solution and incubate. 4. Add substrate TMB and incubate. 5. Add stop solution and measure OD value. 6. Calculation of results.
Materials
• Sample Type: Serum, plasma or cell culture supernatant